<DOC>
	<DOCNO>NCT01041768</DOCNO>
	<brief_summary>200 type 2 diabetic patient -BMI 30-35- submit bariatric surgery ( biliopancreatic diversion BPD gastric bypass GBP ) 100 receive standard medical treatment . Subjects monitor 5 year period ass effect surgical procedure diabetes resolution control 1 , 3 5 year .</brief_summary>
	<brief_title>Multicentric Prospective Randomized Trial Surgery Versus Standard Medical Care Type 2 Diabetic Patients BMI 30-35</brief_title>
	<detailed_description>The study multicentric prospective 2-arm randomize controlled trial . Only Centers least 50 bariatric surgery perform time window January 2007 September 2008 allow participate study . Each Collaborating Center participate study perform one type surgical procedure ( GBP BPD ) , depend one familiar . Patients randomly assign 2 1 ratio receive either bariatric surgery ( BS ) ( either GBP BPD ) standard antidiabetic care ( AC ) . The randomization centralize Coordinating Center . Patients assign BS undergo GBP BPD , depend Collaborating Center . Recruitment continue , independently number recruited patient per center , target 200 GBP+BPD patient , 100 AC patient attain . After one year since enrollment , patient AC group offer choice undergo one two surgical procedure , follow protocol study surgical patient . In addition , Collaborating Center responsible select one diabetic subject operate patient , match closely possible patient assign surgical therapy , local population medical treatment . These patient serve control long term mortality morbidity .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>BMI ≥30 ≤34.9 kg/m2 age 35 70 year duration diabetes ≥ 5 year poor glycemic control ( i.e. , HbA1c ≥ 8 % ) spite medical antidiabetic therapy accordance good clinical practice ( GCP ) presence significant comorbidities complication ( dyslipidemia , arterial hypertension , impaired renal function , neuropathy , retinopathy , CVD ) specific contraindication obesity surgery GBP BPD , include gastric alteration specifically contraindicate GBP HbA1c &lt; 8 % positive autoantibody antipancreas islet serum Cpeptide &lt; 0.5 ng/ml pregnancy medical condition require acute hospitalisation severe diabetes complication associate medical condition ( blindness , endstage renal failure , liver cirrhosis , malignancy , chronic congestive heart failure recent ( within precede 12 month ) myocardial infarction , stroke TIA unstable angina pectoris psychological condition may hamper patient 's cooperation geographic inaccessibility condition , judgement Investigator , may make risky participation study bias result</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
</DOC>